Gas chromatography (GC) e-nose data combines with e-eye, and e-tongue data to profile vegetable breads.
|Articles|July 22, 2016
- LCGC Europe-08-01-2016
- Volume 29
- Issue 8
Supplementary Information: Applying LC with Low-Resolution MS/MS and Subsequent Library Search for Reliable Compound Identification in Systematic Toxicological Analysis
Supplementary Tables
Advertisement
This information is supplementary to the article “Applying LC with Low-Resolution MS/MS and Subsequent Library Search for Reliable Compound Identification in Systematic Toxicological Analysis” that was published in the August 2016 issue of LCGC Europe.
Articles in this issue
about 10 years ago
Microscale Separations and Bioanalysis (MSB 2017)over 10 years ago
How Does It Work? Part 4: Ultraviolet Detectorsover 10 years ago
Know Your Sample: Size Mattersover 10 years ago
Separation Science in Drug Development, Part 4: Quality Controlover 10 years ago
Company Profilesover 10 years ago
Vol 29 No 8 LCGC Europe August 2016 Regular Issue PDFAdvertisement
Related to this article
Gas chromatography–mass spectrometry (GC–MS) shows vapers mostly know whether their e-liquid is high in nicotine.
This week, Chromatography Online’s coverage included LCGC Lifetime Achievement and Emerging Leader award winners, chiral gas chromatography (GC), and artificial intelligence (AI)-driven liquid chromatography (LC) methods.
Ultrahigh-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) traces Suhexiang Wan compounds that reach the stroke-impared brain.
Ultrahigh-performance liquid chromatography–mass spectrometry (UHPLC–MS) finds tomato alkaloids modestly absorbed and largely metabolized in the blood.
Robert T. Kennedy and María José Trujillo-Rodríguez win the 2027 LCGC Lifetime Achievement and Emerging Leader in Chromatography Awards.
High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
Nano-liquid chromatography-high-resolution tandem mass spectrometry (nano-LC-HRMS/MS) reveals saliva protein shifts before and after multiple sclerosis therapy.
Advertisement
Advertisement